TXN2
Thioredoxin, mitochondrial
Also known as: MT-TRX, THIOM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99757
- Gene
- TXN2
- Ensembl
- ENSG00000100348
- Chromosome
- 22
- Canonical length
- 166 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This nuclear gene encodes a mitochondrial member of the thioredoxin family, a group of small multifunctional redox-active proteins. The encoded protein may play important roles in the regulation of the mitochondrial membrane potential and in protection against oxidant-induced apoptosis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
166 residues, UniProt reviewed canonical sequence.
>Q99757|TXN2
1 MAQRLLLRRF LASVISRKPS QGQWPPLTSR ALQTPQCSPG GLTVTPNPAR TIYTTRISLT
61 TFNIQDGPDF QDRVVNSETP VVVDFHAQWC GPCKILGPRL EKMVAKQHGK VVMAKVDIDD
121 HTDLAIEYEV SAVPTVLAMK NGDVVDKFVG IKDEDQLEAF LKKLIGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TXN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 177 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 177 nTPM
- tongue: 168 nTPM
- skeletal muscle: 151 nTPM
- liver: 149 nTPM
- heart muscle: 124 nTPM
- choroid plexus: 123 nTPM
Single-cell type
- extravillous trophoblasts: 341 nCPM
- oocytes: 332 nCPM
- esophageal suprabasal cells: 294 nCPM
- esophageal basal cells: 268 nCPM
- migrating cytotrophoblasts: 258 nCPM
- cytotrophoblasts: 251 nCPM
Immune cell
- total PBMC: 224 nTPM
- myeloid DC: 224 nTPM
- intermediate monocyte: 194 nTPM
- classical monocyte: 174 nTPM
- non-classical monocyte: 171 nTPM
- plasmacytoid DC: 167 nTPM
Brain region
- thalamus: 83 nTPM
- cerebellum: 76 nTPM
- medulla oblongata: 73 nTPM
- choroid plexus: 72 nTPM
- pons: 71 nTPM
- midbrain: 71 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TXN2.
Disease | AllUniProt
Conditions TXN2 is implicated in, by any mechanism.
- Combined oxidative phosphorylation deficiency 29 (COXPD29) MIM:616811
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 78 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined oxidative phosphorylation deficiency 29
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor
- protein-disulfide reductase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TXN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TXN2 as an antibody target. Whether an autoantibody or antibody against TXN2 could matter depends on whether native TXN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TXN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TXN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...